Your browser doesn't support javascript.
loading
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
Staehler, M; Motzer, R J; George, D J; Pandha, H S; Donskov, F; Escudier, B; Pantuck, A J; Patel, A; DeAnnuntis, L; Bhattacharyya, H; Ramaswamy, K; Zanotti, G; Lin, X; Lechuga, M; Serfass, L; Paty, J; Ravaud, A.
Afiliación
  • Staehler M; Department of Urology, University Hospital of Munich, Munich, Germany. Electronic address: michael.staehler@med.uni-muenchen.de.
  • Motzer RJ; Department of Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • George DJ; Division of Oncology, Duke Cancer Center, Durham, USA.
  • Pandha HS; Department of Clinical and Experimental Medicine, University of Surrey, Surrey, UK; Department of Microbial Sciences, University of Surrey, Surrey, UK.
  • Donskov F; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Escudier B; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Pantuck AJ; Department of Urology, Ronald Reagan UCLA Medical Center, Los Angeles, USA.
  • Patel A; Spire Roding Hospital, London, UK.
  • DeAnnuntis L; Pfizer Inc., Collegeville, USA.
  • Bhattacharyya H; Pfizer Inc., New York, USA.
  • Ramaswamy K; Pfizer Inc., New York, USA.
  • Zanotti G; Pfizer Inc., New York, USA.
  • Lin X; Pfizer Inc., La Jolla, USA.
  • Lechuga M; Pfizer S.r.L, Milan, Italy.
  • Serfass L; Pfizer Oncology, Paris, France.
  • Paty J; Quintiles IMS, Pittsburg, USA.
  • Ravaud A; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.
Ann Oncol ; 29(10): 2098-2104, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30412222
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Carcinoma de Células Renales / Medición de Resultados Informados por el Paciente / Sunitinib / Neoplasias Renales / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Carcinoma de Células Renales / Medición de Resultados Informados por el Paciente / Sunitinib / Neoplasias Renales / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article